CAPPED BONUSZERTIFIKAT - MERCK & CO. Share Price

Certificat

DE000PC67NE3

Market Closed - Börse Stuttgart 12:49:03 28/05/2024 pm IST
109.3 EUR -0.80% Intraday chart for CAPPED BONUSZERTIFIKAT - MERCK & CO.
Current month-1.51%
1 month-1.13%
Date Price Change
28/24/28 109.3 -0.80%
27/24/27 110.1 -0.55%
24/24/24 110.8 +0.08%
23/24/23 110.7 +0.24%
22/24/22 110.4 +0.13%

Delayed Quote Börse Stuttgart

Last update May 28, 2024 at 12:49 pm IST

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC67NE
ISINDE000PC67NE3
Date issued 25/03/2024
Strike 140 $
Maturity 19/12/2025 (570 Days)
Parity 1 : 1
Emission price 104
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 111.3
Lowest since issue 106.4
Spread 0.02
Spread %0.02%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
126.1 USD
Average target price
141.9 USD
Spread / Average Target
+12.52%
Consensus